Published: 25 November 2022
Author(s): Philippe Debourdeau, Simon Launay, Malika Chaouche
Section: Letter to the Editor
The incidence of Venous Thromboembolism (VTE) in patients with pancreatic cancer is high, especially in individuals with locally advanced or metastatic disease treated with chemotherapy, as outlined in this retrospective study where the incidence reaches 22% [1].